KalVista Pharmaceuticals, Inc.

KALV

—

Advanced chart & tools →

KalVista Pharmaceuticals, Inc.KALV

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.69

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$50.00M

Net income

$-183.44M

Net margin

-366.9%

Gross margin

—

Dividends & financials

KalVista Pharmaceuticals, Inc. (KALV) reported revenue of $50.00M and net income of $-183.44M, or $-3.69 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.